Using a scoring system could allow health systems and pharmacies to identify a range of manufacturers who can meet their supply needs, potentially at a lower cost. (Photo: Shutterstock)
How effective is that generic drug you just picked up from the pharmacy? The regulations governing the approval of bo-similars has led to a perception that all generic drugs are created equal, when, in fact, that's not necessarily the case. Generic drugs are increasingly being manufactured overseas, where oversight and regulations are much more lax.
Pointing to a long list of drug quality issues that includes contamination of critical blood pressure medications, heartburn medications and diabetes medications with carcinogens (have you gotten around to throwing out that bottle of Zantac yet?), a group of pharmacists is calling for the creation of a quality score system.
Recommended For You
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Emily Payne
Emily Payne is director, content analytics for ALM's Business & Finance Markets and former managing editor for BenefitsPRO. A Wisconsin native, she has spent the past decade writing and editing for various athletic and fitness publications. She holds an English degree and Business certificate from the University of Wisconsin.
